Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Accelerated Stability Testing of Ointments – V 2.0

Posted on By

SOP for Accelerated Stability Testing of Ointments – V 2.0

Procedure for Accelerated Stability Testing of Ointments

Department Quality Control (QC)/Quality Assurance (QA)/Research & Development (R&D)
SOP No. SOP/Ointment/101
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for conducting accelerated stability testing of ointments to evaluate the product’s physical, chemical, and microbiological stability under stressed environmental conditions.

2. Scope

This SOP applies to all personnel in the Quality Control (QC), Quality Assurance (QA), and Research & Development (R&D) departments involved in performing, monitoring, and documenting accelerated stability studies for ointments.

3. Responsibilities

  • QC Analyst: Conducts stability testing as per the protocol.
  • QC Supervisor: Ensures adherence to test conditions and data integrity.
  • QA Officer: Reviews and approves stability testing reports.
  • R&D Scientist: Interprets data and suggests formulation improvements if needed.
  • QA Manager: Approves stability study protocols and ensures regulatory compliance.
See also  Ointments: SOP for pH Adjustment During Ointment Development - V 2.0

4. Accountability

The QA and QC Managers are accountable for ensuring compliance with stability testing guidelines as per ICH Q1A(R2).

5. Procedure

5.1 Preparation for Stability Testing

  • Ensure that the stability study protocol is approved before initiating testing.
  • Select representative ointment batches for testing.
  • Label stability samples with batch number, manufacturing date, and storage conditions.
  • Store samples under specified accelerated conditions as per
ICH guidelines (e.g., 40°C ± 2°C/75% RH ± 5% RH).

5.2 Stability Testing Parameters

  • Physical Properties: Observe changes in color, odor, texture, phase separation.
  • Chemical Stability: Assess the active ingredient assay using validated analytical methods.
  • Microbiological Testing: Perform microbial limit tests to check for contamination.
  • pH Measurement: Record any variations in pH levels over time.
  • Viscosity Analysis: Evaluate consistency and spreadability.

5.3 Sampling Intervals

  • Collect stability samples at predefined intervals: 0, 1, 2, 3, and 6 months.
  • Perform tests as per the stability study protocol.
  • Record all observations in the Stability Testing Log.

5.4 Handling Out-of-Specification (OOS) Results

  • Identify any deviations from the acceptance criteria.
  • Initiate an OOS investigation if required.
  • Implement corrective and preventive actions (CAPA) if necessary.

5.5 Documentation and Data Analysis

  • Record all test results in the Stability Study Report.
  • Ensure data integrity and traceability.
  • QA must approve stability data before finalizing the report.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • ICH – International Council for Harmonisation
  • RH – Relative Humidity
  • OOS – Out-of-Specification

7. Documents

  • Stability Testing Log (Annexure-1)
  • Accelerated Stability Study Report (Annexure-2)

8. References

  • ICH Q1A(R2) Stability Testing of New Drug Substances and Products
  • WHO GMP Guidelines for Pharmaceutical Stability Studies

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stability Testing Log

Date Batch Number Storage Condition Testing Interval Parameter Tested Result Reviewed By
01/02/2025 OINT-101 40°C/75% RH 1 Month Viscosity Compliant QA Officer
01/03/2025 OINT-101 40°C/75% RH 3 Months pH Stable QA Officer

Annexure-2: Accelerated Stability Study Report

Batch Number Study Start Date Study End Date Test Parameters Results Final Conclusion
OINT-101 01/02/2025 01/08/2025 pH, Viscosity, Microbial Limits Compliant Meets Stability Criteria
OINT-102 01/03/2025 01/09/2025 Appearance, Assay, Microbial Limits Compliant Meets Stability Criteria

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
See also  Ointments: SOP for Testing Ointment Viscosity - V 2.0
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Job Safety Analysis for Compression Tooling Inspection Machine
Next Post: Aerosol: SOP for Maintaining Manufacturing Process Parameters – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version